Yolk-sac-derived macrophages progressively expand in the mouse kidney with age.
aging
human biology
immunology
inflammation
kidney
macrophage ontogeny
medicine
mouse
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
17 04 2020
17 04 2020
Historique:
received:
10
09
2019
accepted:
16
04
2020
pubmed:
18
4
2020
medline:
30
3
2021
entrez:
18
4
2020
Statut:
epublish
Résumé
Renal macrophages represent a highly heterogeneous and specialized population of myeloid cells with mixed developmental origins from the yolk-sac and hematopoietic stem cells (HSC). They promote both injury and repair by regulating inflammation, angiogenesis, and tissue remodeling. Recent reports highlight differential roles for ontogenically distinct renal macrophage populations in disease. However, little is known about how these populations change over time in normal, uninjured kidneys. Prior reports demonstrated a high proportion of HSC-derived macrophages in the young adult kidney. Unexpectedly, using genetic fate-mapping and parabiosis studies, we found that yolk-sac-derived macrophages progressively expand in number with age and become a major contributor to the renal macrophage population in older mice. This chronological shift in macrophage composition involves local cellular proliferation and recruitment from circulating progenitors and may contribute to the distinct immune responses, limited reparative capacity, and increased disease susceptibility of kidneys in the elderly population. Older people are more likely to develop kidney disease, which increases their risk of having other conditions such as a heart attack or stroke and, in some cases, can lead to their death. Older kidneys are less able to repair themselves after an injury, which may help explain why aging contributes to kidney disease. Another possibility is that older kidneys are more susceptible to excessive inflammation. Learning more about the processes that lead to kidney inflammation in older people might lead to better ways to prevent or treat their kidney disease. Immune cells called macrophages help protect the body from injury and disease. They do this by triggering inflammation, which aides healing. Too much inflammation can be harmful though, making macrophages a prime suspect in age-related kidney harm. Studying these immune cells in the kidney and how they change over the lifespan could help scientists to better understand age-related kidney disease. Now, Ide, Yahara et al. show that one type of macrophage is better at multiplying in older kidneys. In the experiments, mice were genetically engineered to make a fluorescent red protein in one kind of macrophage. This allowed Ide, Yahara et al. to track these immune cells as the mice aged. The experiments showed that this subgroup of cells is first produced when the mice are embryos. They stay in the mouse kidneys into adulthood, and are so prolific that, over time, they eventually become the most common macrophage in older kidneys. The fact that one type of embryonically derived macrophage takes over with age may explain the increased inflammation and reduced repair capacity seen in aging kidneys. More studies will help scientists to understand how these particular cells contribute to age-related changes in susceptibility to kidney disease.
Autres résumés
Type: plain-language-summary
(eng)
Older people are more likely to develop kidney disease, which increases their risk of having other conditions such as a heart attack or stroke and, in some cases, can lead to their death. Older kidneys are less able to repair themselves after an injury, which may help explain why aging contributes to kidney disease. Another possibility is that older kidneys are more susceptible to excessive inflammation. Learning more about the processes that lead to kidney inflammation in older people might lead to better ways to prevent or treat their kidney disease. Immune cells called macrophages help protect the body from injury and disease. They do this by triggering inflammation, which aides healing. Too much inflammation can be harmful though, making macrophages a prime suspect in age-related kidney harm. Studying these immune cells in the kidney and how they change over the lifespan could help scientists to better understand age-related kidney disease. Now, Ide, Yahara et al. show that one type of macrophage is better at multiplying in older kidneys. In the experiments, mice were genetically engineered to make a fluorescent red protein in one kind of macrophage. This allowed Ide, Yahara et al. to track these immune cells as the mice aged. The experiments showed that this subgroup of cells is first produced when the mice are embryos. They stay in the mouse kidneys into adulthood, and are so prolific that, over time, they eventually become the most common macrophage in older kidneys. The fact that one type of embryonically derived macrophage takes over with age may explain the increased inflammation and reduced repair capacity seen in aging kidneys. More studies will help scientists to understand how these particular cells contribute to age-related changes in susceptibility to kidney disease.
Identifiants
pubmed: 32301704
doi: 10.7554/eLife.51756
pii: 51756
pmc: PMC7205460
doi:
pii:
Substances chimiques
CX3C Chemokine Receptor 1
0
Csf1r protein, mouse
0
Cx3cr1 protein, mouse
0
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIA NIH HHS
ID : R01 AG049745
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR027528
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI088100
Pays : United States
Informations de copyright
© 2020, Ide et al.
Déclaration de conflit d'intérêts
SI, YY, YK, SS, KI, AW, SX, JP, SC, MS, BA, TS No competing interests declared
Références
JCI Insight. 2016 Jul 21;1(11):e87680
pubmed: 27699223
Immunity. 2013 Apr 18;38(4):792-804
pubmed: 23601688
Immunity. 2013 Jan 24;38(1):79-91
pubmed: 23273845
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Cell. 2018 Oct 4;175(2):400-415.e13
pubmed: 30173915
Science. 2016 Feb 12;351(6274):aad5510
pubmed: 26797145
Nat Rev Nephrol. 2019 Oct;15(10):625-640
pubmed: 31477915
Immunity. 2014 Jan 16;40(1):91-104
pubmed: 24439267
Immunity. 2015 Apr 21;42(4):665-78
pubmed: 25902481
J Exp Med. 2008 May 12;205(5):1187-99
pubmed: 18458114
Nat Immunol. 2014 Oct;15(10):929-937
pubmed: 25151491
Immunity. 2016 Sep 20;45(3):597-609
pubmed: 27590115
Kidney Int. 2019 Apr;95(4):760-773
pubmed: 30827512
Science. 2016 Sep 9;353(6304):
pubmed: 27492475
J Exp Med. 2014 Oct 20;211(11):2151-8
pubmed: 25245760
Nat Cell Biol. 2020 Jan;22(1):49-59
pubmed: 31907410
N Engl J Med. 2014 Jul 3;371(1):58-66
pubmed: 24988558
Immunity. 2017 Aug 15;47(2):323-338.e6
pubmed: 28813661
Cell. 2017 Aug 24;170(5):860-874.e19
pubmed: 28803730
Science. 2010 Nov 5;330(6005):841-5
pubmed: 20966214
Int Immunol. 2018 Oct 29;30(11):493-501
pubmed: 29986024
Cell Immunol. 2018 Aug;330:97-104
pubmed: 29748002
Nat Commun. 2018 Jan 8;9(1):75
pubmed: 29311541
JCI Insight. 2019 Jan 24;4(2):
pubmed: 30674729
Nat Commun. 2016 Jun 13;7:ncomms11852
pubmed: 27292029
J Am Soc Nephrol. 2018 Jan;29(1):138-154
pubmed: 29217759
Cell. 2016 Aug 11;166(4):991-1003
pubmed: 27477514
Nature. 2015 Feb 26;518(7540):547-51
pubmed: 25470051
Elife. 2019 Feb 13;8:
pubmed: 30758286
Nat Immunol. 2019 Jan;20(1):29-39
pubmed: 30538339